论文部分内容阅读
目的探讨冠心病患者血清超敏C-反应蛋白(hs-cRP)水平及临床意义。方法选择住院冠心病患者组110例,其中稳定型心绞痛(SAP)34例,不稳定型心绞痛(UAP)34例,急性心肌梗死(AMI)42例。对照组50例,采用免疫比浊法检测hs-CRP水平。结果冠心病组的血清hs-CRP水平显著高于正常对照组(P<0.01),冠心病组AMI患者的血清hs-CRP水平较SAP、UAP显著升高(P<0.01)。结论冠心病患者hs-CRP水平可作为判断病情的客观指标。
Objective To investigate the serum hs-cRP level and its clinical significance in patients with coronary heart disease. Methods One hundred and ten hospitalized patients with coronary heart disease were selected, including 34 cases of stable angina pectoris (SAP), 34 cases of unstable angina pectoris (UAP) and 42 cases of acute myocardial infarction (AMI). Control group of 50 cases, the use of immune turbidimetry hs-CRP levels. Results Serum hs-CRP level in CHD group was significantly higher than that in normal control group (P <0.01). Serum hs-CRP levels in AMI group were significantly higher than those in SAP group and UAP group (P <0.01). Conclusion The level of hs-CRP in patients with coronary heart disease can be used as an objective indicator of the disease.